YOUR BUSINESS AUTHORITY
Springfield, MO
YOUR BUSINESS AUTHORITY
Springfield, MO
Bristol Myers Squibb Co. was sued for $6.4 billion late last week.
The company is accused of allegedly delaying its Breyanzi cancer drug to avoid payments to shareholders of Celgene Corp., which it purchased in 2019.
The lawsuit was filed by UMB Bank, which is acting as a trustee on behalf of Celgene's former shareholders.
Read more from Reuters.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Caterpillar to acquire John Fabick Tractor Co.
Eric Schmitt introduces Modern Skies Act
Springfield airport to cut the ribbon on $35M in construction projects
Legacy Bank accused in lawsuit of failing to protect customers in data breach